Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: bluebird, NeuroDerm raise follow-ons

    bluebird bio Inc. (NASDAQ:BLUE) and NeuroDerm Ltd. (NASDAQ:NDRM) each priced follow-on offerings, raising a combined $325 million.bluebird raised $250 million through the sale of 3.3 million shares at $76 in a deal …

    Published on 12/7/2016
  • FINANCIAL NEWS: Nordic Nanovector prices private placement

    Nordic Nanovector ASA (OSE:NANO) raised NOK498.7 million ($59.2 million) through the sale of 4.4 million shares at NOK114 in a private placement. DNB Markets, Jefferies and ABG Sundal Collier were underwriters. Nordic …

    Published on 12/7/2016
  • FINANCIAL NEWS: Quintiles IMS: Drug price increases to slow

    In a new report describing its outlook for pharmaceutical spending, Quintiles IMS Holdings Inc. (NYSE:Q) said it expects both list and net prices of U.S. drugs to grow more slowly in the next five years than in recent …

    Published on 12/7/2016
  • FINANCIAL NEWS: TCR2 raises $44.5M in series A round

    Immuno-oncology company TCR2 Therapeutics Inc. (Cambridge, Mass.) raised $44.5 million in a series A round led by MPM Capital and F2 Ventures.The company plans to develop T cell therapies based on its T cell receptor (…

    Published on 12/7/2016
  • FINANCIAL NEWS: Gladstone launches Tenaya with $50M series A round

    The Gladstone Institutes said it launched cardiovascular newco Tenaya Therapeutics Inc. (San Francisco, Calif.) with a $50 million series A round. Tenaya President JJ Kang told BioCentury that The Column Group …

    Published on 12/6/2016
  • FINANCIAL NEWS: Oxford Biodynamics ticks up after IPO

    Biomarkers company Oxford Biodynamics plc (LSE:OBD) gained 1p to 159p in its first day of trading Tuesday. Last week, the company raised L7.1 million ($8.8 million) through the sale of 4.5 million shares at 158p. …

    Published on 12/6/2016
  • FINANCIAL NEWS: SillaJen slips in first trading day

    SillaJen Inc. (KOSDAQ:215600) lost W2,150 (14%) to W12,850 in its first day of trading Tuesday after it raised W150 billion ($135 million) through the sale of 10 million shares at W15,000 in an IPO.The company is …

    Published on 12/6/2016
  • FINANCIAL NEWS: Takeda, Lightstone back CNS newco Cerevance

    Neurology newco Cerevance LLC (Cambridge, Mass.) launched with $36 million, including a $21.5 million series A from co-leaders Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) and Lightstone Ventures. Cerevance declined to …

    Published on 12/2/2016
  • FINANCIAL NEWS: V-Bio closes EUR 76M fund

    V-Bio Ventures closed its first life sciences fund at EUR 76 million ($81 million). LPs include the European Investment Fund (EIF), PMV-ARKimedes, Korys, KU Leuven, Gimv, SFPI-FPIM, BNP Paribas Fortis Private Equity and…

    Published on 12/1/2016
  • FINANCIAL NEWS: CRUK leads massive investment in cancer research

    Cancer Research U.K. said it will invest L190 million ($237.4 million) across 13 CRUK centers over the next five years.Along with several public institutions, the charity will also provide an additional L36 million ($45…

    Published on 11/30/2016
  • FINANCIAL NEWS: dMed raises $8M in first round

    CRO and consultancy dMed Co. Ltd. (Shanghai, China) raised $8 million in its first round of financing. Qiming Venture Capital led the round. Tairui Investment and Zai Lab Ltd. (Shanghai, China) also participated.dMed …

    Published on 11/30/2016
  • FINANCIAL NEWS: Microbiome newco Axial raises $19.2M

    Axial Biotherapeutics Inc. (Boston, Mass.) raised $19.2 million in a series A round, with which it hopes to develop microbiome-based treatments for CNS disorders. Longwood Fund and Domain Associates co-led the round. …

    Published on 11/30/2016
  • FINANCIAL NEWS: Novogene raises $75M in series B round

    Genomic services company Beijing Novogene Bioinformatics Technology Co. Ltd. (Beijing, China) raised $75 million in a series B round led by CMB International, SDIC Innovation and Sigma Square Capital. The company …

    Published on 11/30/2016
  • FINANCIAL NEWS: OxThera raises EUR 32M

    OxThera AB (Uppsala, Sweden) raised EUR 32 million ($34.1 million) in a round co-led by LSP, Ysios Capital, Sunstone Capital and Flerie Invest. Also participating were existing investors Kurma Partners, Idinvest …

    Published on 11/30/2016
  • FINANCIAL NEWS: TraceLink raises $51.5M in series C round

    Supply chain technology company TraceLink Inc. (North Reading, Mass.) raised a $51.5 million series C round led by Goldman Sachs Growth Equity. Also participating were FirstMark Capital, Volition Capital and F-Prime …

    Published on 11/30/2016
  • FINANCIAL NEWS: Actelion gains again as takeout rumors swirl

    Actelion Ltd. (SIX:ATLN) climbed CHF19 (10%) to CHF209 on Tuesday after media reports said Johnson & Johnson (NYSE:JNJ) raised its bid to acquire the company. Actelion shares have gained 32% since closing at CHF158 on …

    Published on 11/29/2016
  • FINANCIAL NEWS: Amicus sinks after revealing slower migalastat timeline

    Amicus Therapeutics Inc. (NASDAQ:FOLD) slipped $1.81 (22%) to $6.51 on Tuesday after it revealed a new timeline for its planned NDA submission for migalastat (AT1001) to treat Fabry's disease. The company now plans to …

    Published on 11/29/2016
  • FINANCIAL NEWS: Innovent raises $260M series D round

    Chinese mAb play Innovent Biologics Inc. (Suzhou, China) raised $260 million in a series D round led by new investor Future Industry Investment Fund, a fund managed by a State Development & Investment Corp. affiliate. …

    Published on 11/29/2016
  • FINANCIAL NEWS: Nohla raises $43.5M series A round

    Nohla Therapeutics Inc. (Seattle, Wash.) raised $43.5 million in a series A round led by new investor Arch Venture Partners. New investor 5AM Ventures and existing investor Jagen Group also participated. Nohla's lead …

    Published on 11/29/2016
  • FINANCIAL NEWS: Kymab raises $100M in series C round

    Antibody platform company Kymab Group Ltd. (Cambridge, U.K.) raised a $100 million series C round led by new investors ORI Healthcare Fund and Shenzhen Hepalink Pharmaceutical Co. Ltd. (SZSE:002399). Shenzhen Hepalink …

    Published on 11/28/2016
  • FINANCIAL NEWS: CIRM grants Orchard, UCLA $20M for ADA-SCID trial

    Gene therapy company Orchard Therapeutics Ltd. (London, U.K.) said the California Institute for Regenerative Medicine (CIRM) awarded the company and University of California Los Angeles researchers $20 million to …

    Published on 11/23/2016
  • FINANCIAL NEWS: Holiday notice

    BioCentury Extra will not publish on Thursday, Nov. 24, or Friday, Nov. 25, in observance of the Thanksgiving holiday in the U.S. BioCentury Extra will resume publishing on Monday, Nov. 28.

    Published on 11/23/2016
  • FINANCIAL NEWS: Arch raises $408.4M toward ninth fund

    Arch Venture Partners has raised $408.4 million towards its Arch Venture Fund IX LP, according to an SEC filing. The fund's target is $550 million, up from a planned $400 million in March.According to a separate filing,…

    Published on 11/21/2016
  • FINANCIAL NEWS: Aclaris raises $91M in follow-on

    Aclaris Therapeutics Inc. (NASDAQ:ACRS) raised $91 million through the sale of 4 million shares at $22.75 in a follow-on underwritten by Jefferies, Leerink, Guggenheim Securities, William Blair and JPM Securities. The …

    Published on 11/17/2016
  • FINANCIAL NEWS: Biocartis raises EUR 32.7M in private placement

    Molecular diagnostics company Biocartis Group N.V. (Euronext:BCART) raised EUR 32.7 million ($35.1 million) through the sale of 4.1 million shares at EUR 8.05 in a private placement underwritten by Degroof Petercam, KBC…

    Published on 11/17/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993